Soligenix SNGX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Slips CVKD Q1 2026 Earnings Narrower Loss Surprises Clinical Progress Maintained LOVE Q1 2026 Earnings EPS Beats Estimates by 682 PMN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Neurodegenerative Pipeline i3 Verticals IIIV Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment GIGM Q3 2025 Earnings Narrowing Loss Amid Quiet Quarter